Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guijuan Dong

Diagnostic and Prognostic Value of Neutrophil Gelatinase-Associated Lipocalin, Matrix Metalloproteinase-9, and Tissue Inhibitor of Matrix Metalloproteinases-1 for Sepsis in the Emergency Department: An Observational Study

Critical Care

Intensive Care Medicine

2014

English

MicroRNA-92a Inhibits Macrophage Antiviral Response by Targeting Retinoic Acid Inducible Gene-I

Microbiology and Immunology

English

Related publications

Immunohistochemical Expression of Matrix Metalloproteinase -9 and Tissue Inhibitor of Metalloproteinase-1 in Placental Tissue IN Late Severe Preeclampsia

Medical News of North Caucasus

Medicine

2015

English

Prognostic Value of Plasma Neutrophil Gelatinase-Associated Lipocalin for Mortality in Patients With Heart Failure

Circulation. Heart failure

Medicine

Cardiovascular Medicine

Cardiology

2014

English

Immunohistochemical Characterization of the Expression of Matrix Metalloproteinase - 9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase (TIMP-1) in the Invasive Endometrioid Endometrial Carcinoma

Pathologia

2015

English

The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients With Colorectal Cancer

Chirurgia (Bucharest, Romania : 1990)

Surgery

2016

English

Involvement of Matrix Metalloproteinases 2 and 9, Tissue Inhibitor of Metalloproteinases and Apoptosis in Tissue Remodelling in the Sheep Placenta

Reproductive Medicine

Obstetrics

Embryology

2000

English

Thymocyte Development in the Absence of Matrix Metalloproteinase-9/Gelatinase B

Scientific Reports

Multidisciplinary

2016

English

Imbalance Between Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinases 1 Expression by Tumor Cells Implicated in Liver Metastasis From Colorectal Carcinoma.

Kurume Medical Journal

Medicine

2001

English

Plasma Levels and Diagnostic Utility of Macrophage-Colony Stimulating Factor, Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 as Tumor Markers in Cervical Cancer Patients

English

Matrix Metalloproteinase‑2 and ‑9 and Tissue Inhibitor of Metalloproteinase‑1 and ‑2 in Sera and Urine of Patients With Renal Carcinoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Guijuan Dong

Diagnostic and Prognostic Value of Neutrophil Gelatinase-Associated Lipocalin, Matrix Metalloproteinase-9, and Tissue Inhibitor of Matrix Metalloproteinases-1 for Sepsis in the Emergency Department: An Observational Study

MicroRNA-92a Inhibits Macrophage Antiviral Response by Targeting Retinoic Acid Inducible Gene-I

Related publications

Immunohistochemical Expression of Matrix Metalloproteinase -9 and Tissue Inhibitor of Metalloproteinase-1 in Placental Tissue IN Late Severe Preeclampsia

Prognostic Value of Plasma Neutrophil Gelatinase-Associated Lipocalin for Mortality in Patients With Heart Failure

Immunohistochemical Characterization of the Expression of Matrix Metalloproteinase - 9 (MMP-9) and Tissue Inhibitor of Matrix Metalloproteinase (TIMP-1) in the Invasive Endometrioid Endometrial Carcinoma

The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients With Colorectal Cancer

Involvement of Matrix Metalloproteinases 2 and 9, Tissue Inhibitor of Metalloproteinases and Apoptosis in Tissue Remodelling in the Sheep Placenta

Thymocyte Development in the Absence of Matrix Metalloproteinase-9/Gelatinase B

Imbalance Between Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinases 1 Expression by Tumor Cells Implicated in Liver Metastasis From Colorectal Carcinoma.

Plasma Levels and Diagnostic Utility of Macrophage-Colony Stimulating Factor, Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 as Tumor Markers in Cervical Cancer Patients

Matrix Metalloproteinase‑2 and ‑9 and Tissue Inhibitor of Metalloproteinase‑1 and ‑2 in Sera and Urine of Patients With Renal Carcinoma